Testosterone therapy in obliterating arterial lesions in the lower limbs.
D015068:17-Ketosteroids / Q000652:urine; D000368:Aged; D000728:Androgens / Q000652:urine; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002746:Chlorpromazine; D002986:Clinical Trials as Topic; D005080:Exercise Test; D005528:Foot / Q000098:blood supply*; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007383:Intermittent Claudication / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010919:Placebos; D010991:Plethysmography; D011674:Pulse / Q000187:drug effects; D012871:Skin Diseases / Q000139:chemically induced; D013739:Testosterone / Q000627:therapeutic use*; D013997:Time Factors
D015068:17-Ketosteroids; D000728:Androgens; D010919:Placebos; D013739:Testosterone; D002746:Chlorpromazine